Αποτελέσματα Αναζήτησης
12 Νοε 2019 · Patients with CKD stage 5 and a BMI > 30 kg/m 2 undertaking dialysis that may benefit from weight loss for other reasons for example, improved mobility, reduced joint pain.
6 Σεπ 2018 · This systematic review aims to provide a current and comprehensive review of weight reduction interventions in CKD by including both overweight and obese adults at all stages of CKD (including pre dialysis, dialysis, supportive care or kidney transplantation).
16 Οκτ 2020 · For those who fail to achieve weight loss through lifestyle modification, bariatric surgery should be considered because observational studies have shown reductions in risk for estimated glomerular filtration rate decline and kidney failure.
Nearly two thirds of US adults are overweight (body mass index [BMI] ≥25 kg/m 2), and of these, one half are obese (BMI ≥30 kg/m 2) ().Obesity not only is associated with an increase in morbidity, mortality, and reduction in life expectancy but also leads to an increase in the incidence of diabetes, hypertension, and dyslipidemia that are independent risk factors for chronic kidney disease ...
Renal dietitians detailed several approaches to support weight loss among patients with obesity on dialysis, including a focus on “mindful eating,” “exercise,” “education on healthy food choices despite food insecurity,” “food journaling,” and “portion control using the Myplate method.”.
30 Μαρ 2021 · Objectives: This review aimed to evaluate the safety and efficacy of intentional weight loss interventions in overweight and obese adults with CKD; including those with end-stage kidney disease (ESKD) being treated with dialysis, kidney transplantation, or supportive care.
Obesity is an independent risk factor for the development and progression of chronic kidney disease (CKD). We conducted a systematic review to assess the benefits of intentional weight loss in obese subjects with altered glomerular filtration rate (GFR), proteinuria or albuminuria.
